FDAnews Device Daily Bulletin

MEDTRONIC ANNOUNCES CLINICAL TRIALS STRATEGY FOR NEUROLOGICAL AND UROLOGICAL THERAPIES

May 3, 2006
A A

Medtronic, Inc. has announced plans to increase significantly its investment in clinical trials of the company's neurological and urological therapies. The new trials will be designed to establish higher levels of evidence for the therapies' efficacy and cost-effectiveness. Medical Technology Business Europe (http://www.mtbeurope.info/news/2006/605002.htm)